GENEVA, Aug. 31 -- ALNYLAM PHARMACEUTICALS, INC. filed a patent application (US2026/016173) for “METHODS AND COMPOSITIONS FOR TREATING TRANSTHYRETIN (TTR)- ASSOCIATED DISEASES”. With publication no. WO/2026/178451, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....